-
公开(公告)号:US08598216B1
公开(公告)日:2013-12-03
申请号:US13328043
申请日:2011-12-16
申请人: Maurizio Acquasaliente , Didier Houllemare , Geoff Zhang , Pulla Singam , John Morris , Kennan Marsh , Martin Babcock , John Pavlina , Yi Shi , Yuchuan Gong
发明人: Maurizio Acquasaliente , Didier Houllemare , Geoff Zhang , Pulla Singam , John Morris , Kennan Marsh , Martin Babcock , John Pavlina , Yi Shi , Yuchuan Gong
IPC分类号: A61K31/426 , A61K31/41
CPC分类号: C07D277/18
摘要: The invention relates to ritonavir bis-hydrochloride, processes for the preparation of the ritonavir bis-hydrochloride, pharmaceutical compositions containing the ritonavir bis-hydrochloride and made from it, and methods of using the ritonavir bis-hydrochloride to inhibit HIV protease or enhance the pharmacokinetics of compounds which are metabolized by cytochrome P450 3A4.
摘要翻译: 本发明涉及利托那韦双盐酸盐,制备利托那韦双盐酸盐的方法,含有利托那韦双盐酸盐并由其制备的药物组合物,以及使用利托那韦双盐酸盐抑制HIV蛋白酶或增强药代动力学的方法 的化合物,其被细胞色素P450 3A4代谢。
-
公开(公告)号:US20050250795A1
公开(公告)日:2005-11-10
申请号:US11131646
申请日:2005-05-18
申请人: M. Leanna , Steven Hannick , Michael Rasmussen , Jien-Heh Tien , Lakshmi Bhagavatula , Pulla Singam , Bradley Gates , Lawrence Kolaczkowski , Ramesh Patel , Greg Wayne , Greg Lannoye , Weijiang Zhang , Zhenping Tian , Kirill Lukin , Bikshandarkoil Narayanan , David Riley , Howard Morton , Sou-Jen Chang , Cynthia Curty , Daniel Plata , John Bellettini , Bhadra Shelat , Tiffany Spitz , Cheng-Xi Yang
发明人: M. Leanna , Steven Hannick , Michael Rasmussen , Jien-Heh Tien , Lakshmi Bhagavatula , Pulla Singam , Bradley Gates , Lawrence Kolaczkowski , Ramesh Patel , Greg Wayne , Greg Lannoye , Weijiang Zhang , Zhenping Tian , Kirill Lukin , Bikshandarkoil Narayanan , David Riley , Howard Morton , Sou-Jen Chang , Cynthia Curty , Daniel Plata , John Bellettini , Bhadra Shelat , Tiffany Spitz , Cheng-Xi Yang
IPC分类号: C07D473/18 , A61K31/522 , C07B53/00 , C07B61/00 , C07C303/30 , C07C309/45 , C07C309/73 , C07D473/00 , C07D473/12 , C07D473/32 , C07D473/40
CPC分类号: C07D473/00 , C07C309/73 , C07D473/18 , Y02P20/55
摘要: Methods and novel intermediates for the preparation of acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H; or a pharmaceutically acceptable salt thereof.
摘要翻译: 用于制备下式的无环核苷衍生物的方法和新型中间体:其中R 1和R 2中的一个是氨基酸酰基,另一个是R 1和R 2是-C(O)C 3 -C 21饱和或单不饱和的任选取代的烷基和 R 3是OH或H; 或其药学上可接受的盐。
-